Aprea Therapeutics Inc.

NASDAQ: APRE · Real-Time Price · USD
1.71
0.02 (1.18%)
At close: Aug 15, 2025, 3:59 PM
1.73
0.96%
Pre-market: Aug 18, 2025, 08:06 AM EDT

Aprea Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-12.96M -14.29M -112.66M -37.13M
Depreciation & Amortization
22.32K 7.05K 186.44K 271.68K
Stock-Based Compensation
489.44K 444.46K 16.98M 7.81M
Other Working Capital
-741.19K 791.25K -900.07K -5.6M
Other Non-Cash Items
-54.37K 38.93K 72.24M -317.4K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-1.06M 1.62M -1.76M -8.33M
Operating Cash Flow
-13.56M -12.18M -25.01M -37.69M
Capital Expenditures
-15.48K -93.09K n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-15.48K -93.09K n/a n/a
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-1.32M -648.93K n/a 208.37K
Financial Cash Flow
14.82M 5.14M 682.97K 1.75M
Net Cash Flow
1.24M -7.14M -24.29M -35.94M
Free Cash Flow
-13.57M -12.27M -25.01M -37.69M